Ligands
Several selective antagonists for the PAR1 receptor have been developed, for use as anti-clotting agents for the treatment of heart disease.
- SCH-530,348
Read more about this topic: Coagulation Factor II Receptor
Ligands
Several selective antagonists for the PAR1 receptor have been developed, for use as anti-clotting agents for the treatment of heart disease.
Read more about this topic: Coagulation Factor II Receptor